INTRODUCTION It has long been understood that psoriasis has a hereditary and familial component. Psoriasis seems to be more common among some ethnic groups, with a prevalence of up to…

Genentech Submits New Drug Application to FDAGenentech has announced that it has submitted a New Drug Application for vismodegib to the FDA for the treatment of people with advanced basal…

TATTOO REMOVAL Topical Imiquimod in Conjunction With Nd:YAG Laser for Tattoo Removal Sponsored by the University of Miami and in collaboration by Graceway Pharmaceauticals, LLC, this study aims to evaluate…

INTRODUCTION The early history of liposuction begins with Fischer's description of hollow cannula liposuction in 1976.1 In 1983, Ilouz, a Frenchman trained in obstetrics and gynecology, and Fournier, a general…

INTRODUCTION Polyacrylamide hydrogels (PAAH) have been used for many years in European and Asian countries, and they have been and some still are produced by a number of different manufacturers…

INTRODUCTION Rosacea, which affects approximately 16 million Americans (mostly adults 30-60 years of age), is associated with frequent flushing, inflammation, and at times a burning sensation.1,2 There is no cure…

INTRODUCTION Acne vulgaris (acne) is a common dermatological disease seen typically in adolescence and young adulthood. It affects approximately 85 percent of individuals at some point in their lives, generally…

INTRODUCTIONHand dermatitis is considered to be quite common, and it is estimated that between two percent and 10 percent of the general population is affected by this skin condition.1 Hand…

INTRODUCTIONAndrogenetic alopecia (AGA) in women or female-pattern hair loss (FPHL) affects a significant percentage of women with increased prevalence with aging; over 70 percent of patients in the seventh decade…

INTRODUCTION In 1975 Gilliam et al. divided the manifestations of cutaneous lupus into acute, subacute, and chronic categories based on clinical-histopathologic lesional patterns. The most common type of chronic lupus…

INTRODUCTION Chronic urticaria (CU) has a lifelong prevalence of 0.5-1% in the United States.1 Reports have demonstrated that the disability suffered by CU patients is similar to that of patients…